产品研发小组/神经调控治疗/The Hypoglossal Nerve Stimulation as a Novel Therapy for Treating Obstructive Sleep Apnea—A Literature Review：修订间差异

来自NERCN
可视化Wikitext
（Edit summary）
 
（Edit summary）
第1行： 第1行：
{{文章推荐|Reason=整理了大量舌下神经刺激领域的文献，介绍了疗法、植入式设备、手术方法、适应症、作用机制、动物实验、人体实验等内容，并对以上内容进行了客观分析。|Journal=International Journal of Environmental Research and Public Health|PubYear=2021|DOI=10.3390/ijerph18041642|Category_=综述|Domain=神经调控治疗|RecomBy=艾力亚尔|RecomGrp=产品研发小组|ReviewBy=马伯志|Abstract=Obstructive sleep apnea (OSA) is a common sleep disorder that affects all age groups and is associated with many co-morbid diseases (especially cardiovascular diseases). Continuous positive airway pressure (CPAP) is the gold standard for treating OSA. However, adherence to PAP therapy has been a major challenge with an estimated adherence between 20% and 80%. Mandibular advancement devices (MAD) are a good alternative option if used in the appropriate patient. MAD are most effective in mild and moderate OSA but not severe OSA. Surgical options are invasive, not appropriate for severe OSA, and associated with pain and long healing time. Hypoglossal nerve stimulation (HGNS), or upper airway stimulation (UAS), is a novel therapy in treating moderate and severe degrees of OSA in patients who cannot tolerate CPAP therapy. We reviewed the MEDLINE (PubMed) database. The search process yielded 303 articles; 31 met the inclusion and exclusion criteria and were included. We concluded that hypoglossal nerve stimulation is a very effective and novel alternative therapy for moderate and severe OSA in patients who cannot tolerate CPAP therapy. Adherence to HGNS is superior to CPAP. However, more developments are needed to ensure the highest safety profile.|DetaialsDM=舌下神经刺激}}
{{文章推荐|Reason=整理了大量舌下神经刺激领域的文献，介绍了疗法、植入式设备、手术方法、适应症、作用机制、动物实验、人体实验等内容，并对以上内容进行了客观分析。|Journal=International Journal of Environmental Research and Public Health|PubYear=2021|DOI=10.3390/ijerph18041642|Category_=综述|Domain=神经调控治疗|RecomBy=艾力亚尔|RecomGrp=产品研发小组|ReviewBy=马伯志|Abstract=Obstructive sleep apnea (OSA) is a common sleep disorder that affects all age groups and is associated with many co-morbid diseases (especially cardiovascular diseases). Continuous positive airway pressure (CPAP) is the gold standard for treating OSA. However, adherence to PAP therapy has been a major challenge with an estimated adherence between 20% and 80%. Mandibular advancement devices (MAD) are a good alternative option if used in the appropriate patient. MAD are most effective in mild and moderate OSA but not severe OSA. Surgical options are invasive, not appropriate for severe OSA, and associated with pain and long healing time. Hypoglossal nerve stimulation (HGNS), or upper airway stimulation (UAS), is a novel therapy in treating moderate and severe degrees of OSA in patients who cannot tolerate CPAP therapy. We reviewed the MEDLINE (PubMed) database. The search process yielded 303 articles; 31 met the inclusion and exclusion criteria and were included. We concluded that hypoglossal nerve stimulation is a very effective and novel alternative therapy for moderate and severe OSA in patients who cannot tolerate CPAP therapy. Adherence to HGNS is superior to CPAP. However, more developments are needed to ensure the highest safety profile.|DetaialsDM=舌下神经刺激|Citation_=46}}

2024年1月18日 (四) 22:24的版本

推荐理由

整理了大量舌下神经刺激领域的文献，介绍了疗法、植入式设备、手术方法、适应症、作用机制、动物实验、人体实验等内容，并对以上内容进行了客观分析。

文章简介
期刊 International Journal of Environmental Research and Public Health
发表年份 2021
DOI 10.3390/ijerph18041642
类型 综述
领域 神经调控治疗
引用量 46
推荐信息
推荐人 艾力亚尔
审核 马伯志
推荐小组 产品研发小组

摘要

Obstructive sleep apnea (OSA) is a common sleep disorder that affects all age groups and is associated with many co-morbid diseases (especially cardiovascular diseases). Continuous positive airway pressure (CPAP) is the gold standard for treating OSA. However, adherence to PAP therapy has been a major challenge with an estimated adherence between 20% and 80%. Mandibular advancement devices (MAD) are a good alternative option if used in the appropriate patient. MAD are most effective in mild and moderate OSA but not severe OSA. Surgical options are invasive, not appropriate for severe OSA, and associated with pain and long healing time. Hypoglossal nerve stimulation (HGNS), or upper airway stimulation (UAS), is a novel therapy in treating moderate and severe degrees of OSA in patients who cannot tolerate CPAP therapy. We reviewed the MEDLINE (PubMed) database. The search process yielded 303 articles; 31 met the inclusion and exclusion criteria and were included. We concluded that hypoglossal nerve stimulation is a very effective and novel alternative therapy for moderate and severe OSA in patients who cannot tolerate CPAP therapy. Adherence to HGNS is superior to CPAP. However, more developments are needed to ensure the highest safety profile.

细分领域

< | 舌下神经刺激


取自“http://101.6.32.246:2215/index.php?title=产品研发小组/神经调控治疗/The_Hypoglossal_Nerve_Stimulation_as_a_Novel_Therapy_for_Treating_Obstructive_Sleep_Apnea—A_Literature_Review&oldid=1039”